Titan Bio-Tech Ltd. | Small-cap | Healthcare
₹401.75
-0.14%
| Titan Bio-Tech Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 1.6B
Gross Profit 838.2M 53.58%
Operating Income 212.6M 13.59%
Net Income 215.3M 13.76%

Balance Sheet Metrics

Total Assets 1.7B
Total Liabilities 213.0M
Shareholders Equity 1.5B
Debt to Equity 0.14

Cash Flow Metrics

Operating Cash Flow 197.8M
Free Cash Flow 106.8M

Revenue & Profitability Trend

Titan Bio-Tech Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 1.6B 1.6B 1.4B 1.2B 1.4B
Cost of Goods Sold 726.3M 937.4M 856.4M 705.3M 752.8M
Gross Profit 838.2M 703.4M 583.6M 530.2M 669.5M
Operating Expenses 320.2M 120.0M 105.5M 75.1M 61.7M
Operating Income 212.6M 309.5M 270.0M 289.0M 443.7M
Pre-tax Income 243.7M 315.3M 281.2M 289.7M 427.1M
Income Tax 61.0M 78.7M 70.9M 72.8M 110.0M
Net Income 215.3M 248.5M 248.4M 216.8M 317.1M
EPS (Diluted) - ₹30.07 ₹30.06 ₹26.24 ₹36.71

Income Statement Trend

Titan Bio-Tech Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 790.4M 721.7M 683.1M 637.6M 588.3M
Non-Current Assets 956.7M 844.1M 662.1M 443.4M 418.9M
Total Assets 1.7B 1.6B 1.3B 1.1B 1.0B
Liabilities
Current Liabilities 177.4M 191.3M 203.5M 169.5M 192.8M
Non-Current Liabilities 35.7M 140.0M 42.5M 49.0M 89.6M
Total Liabilities 213.0M 331.3M 246.0M 218.5M 282.4M
Equity
Total Shareholders Equity 1.5B 1.3B 1.1B 862.4M 724.8M

Balance Sheet Composition

Titan Bio-Tech Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 243.7M 315.3M 281.2M 289.7M 427.1M
Operating Cash Flow 197.8M 276.0M 245.1M 240.2M 259.6M
Investing Activities
Capital Expenditures -85.3M -86.7M -131.6M -136.8M -48.6M
Investing Cash Flow -98.3M -202.7M -207.2M -164.4M -48.6M
Financing Activities
Dividends Paid -16.5M -14.9M -12.4M -12.4M -8.3M
Financing Cash Flow -67.2M -13.2M -17.7M 110.4M -105.8M
Free Cash Flow 106.8M 14.6M 77.1M 83.6M 142.2M

Cash Flow Trend

Titan Bio-Tech Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 15.48
Price to Book 2.17
Price to Sales 2.13

Profitability Ratios

Profit Margin 13.76%
Operating Margin 10.60%
Return on Equity 15.01%
Return on Assets 8.02%

Financial Health

Current Ratio 4.46
Debt to Equity 1.82
Beta 0.43

Per Share Data

EPS (TTM) ₹26.06
Book Value per Share ₹185.75
Revenue per Share ₹189.36

Financial data is updated regularly. All figures are in the company's reporting currency.